empa-kidney results: empagliflozin reduces kidney disease progression and cardiovascular deaths
Published 2 years ago • 8.2K plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
1:35
empa-kidney: meta-analysis results
-
1:14
empa-kidney results november 2022
-
10:10
empa-kidney results
-
2:33
empa-kidney: introduction to the trial
-
2:41
fda approves empagliflozin for reducing kidney disease progression in ckd patients
-
3:21
empa ckd - 3 min trial summary
-
57:22
emerging data from empa-kidney study
-
11:19
ehj today - the empa-reg outcome trial
-
7:11
is your back pain really a herniated disc? try this simple test and diagnose l4-l5-s1 disc at home
-
40:42
the four pillars of managing diabetic kidney disease with dr brendon neuen
-
1:06:22
empa kidney results: flozins for all ckd with dr will herrington
-
38:48
radcliffe & cardionerds @aha22: empa-kidney: empagliflozin & cv outcomes in patients with ckd
-
2:10
the new chronic kidney disease medicine and treatment option approved | empagliflozin
-
1:08:25
webinar: overview of high impact clinical trials: empa-kidney and stop-acei
-
1:24:14
empagliflozin & kidney disease: the empa-kidney study (live)
-
3:41
jennifer green, easd 2022: finerenone & empagliflozin in patients with ckd and t2d: confidence study
-
9:59
recovery trial - empagliflozin
-
26:33
professor christoph wanner - the kidney as a cardiovascular disease accelerator
-
7:23
empa kidney trial
-
11:52
safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease
-
6:06
esc 2019: empa-reg outcome - dr david fitchett
-
5:38
esc tv on the road - #aha22 - dcp and empa-kidney trials